N/A
Completed N=131
Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root
Nasal Augmentation
Source: ClinicalTrials.gov NCT02216851 ↗
Enrolled (actual)
131
Serious AEs
3.8%
Results posted
Sep 2021
Primary outcomePrimary: Mean Difference of Change in Volume (mL) at 6 Months After Baseline Versus Pre-treatment in the Nasal Dorsum/Nasal Root Between Restylane Perlane Treatment Group and No-treatment Control — 0.82; 0.11 mL
Summary
The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Difference of Change in Volume (mL) at 6 Months After Baseline Versus Pre-treatment in the Nasal Dorsum/Nasal Root Between Restylane Perlane Treatment Group and No-treatment Control |
0.82; 0.11 | — |
Eligibility Criteria
Inclusion Criteria
- Chinese origin
- Subject with desire to shape the nasal dorsum and/or nasal root
- Subjects who, in the opinion of the investigator, can achieve a clinically meaningful aesthetic correction of their nose with ≤ 1 ml Restylane Perlane
Exclusion Criteria
- Subjects with previous nasal surgery, including grafts or implants to the nose area
- Subjects requiring filler treatment around the tip of the nose or between the eyebrows (glabella region) to achieve a good aesthetic outcome
- Subjects with a history of chronic sinusitis or rhinitis
- Subjects who have previously received aesthetic treatment in the forehead, glabellar and/or nose area with a dermal filler
Data sourced from ClinicalTrials.gov (NCT02216851). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.